TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Research and Development Expense in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
Teva Pharmaceutical Industries Ltd annual/quarterly Research and Development Expense history and growth rate from 2011 to 2022.
  • Teva Pharmaceutical Industries Ltd Research and Development Expense for the quarter ending March 31, 2022 was $54M.
  • Teva Pharmaceutical Industries Ltd annual Research and Development Expense for 2022 was $98M.
  • Teva Pharmaceutical Industries Ltd annual Research and Development Expense for 2018 was $114M, a 34.9% decline from 2017.
  • Teva Pharmaceutical Industries Ltd annual Research and Development Expense for 2017 was $175M, a 58.5% decline from 2016.
Research and Development Expense, Annual (USD)
Research and Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $98M Jan 1, 2022 Dec 31, 2022 10-K 2023-02-10
2018 $114M -$61M -34.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-21
2017 $175M -$247M -58.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $422M +$387M +1106% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $35M +$35M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $0 -$5M -100% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 $5M -$68M -93.2% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 $73M +$58M +387% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $15M Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.